CLDN18.2 Positive Solid Tumors
2 clinical trials · Condition
◉ Watch CLDN18.2 Positive Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI345 (NCT05199519) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-12-13 |
Track CLDN18.2 Positive Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.